demonstrated that activation of the epidermal growth factor receptor (EGFR) induces PKM2 nuclear translocation, upregulating cyclin D1 expression in GBM U87 cell lines and other human cancer cells, accelerating tumor formation (91). This evidence concerns the gene EGFR and glioblastoma.